This inventor holds 3 USPTO granted patents. Top assignees: Laboratoires Glaxo S.a., Smithkline Beecham Corporation. Active years: 1997-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2005
Title: Bernard Andre Dumaitre: Innovator in Cardiovascular Treatments
Introduction
Bernard Andre Dumaitre is a notable inventor based in Les Ulis, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating cardiovascular diseases. With a total of 3 patents, his work has had a meaningful impact on medical science.
Latest Patents
Dumaitre's latest patents include innovative compounds such as thiazole or oxazole derivatives, which are useful in the treatment of cardiovascular and related diseases. These compounds are characterized by a specific formula that includes various substituents, providing a foundation for further pharmaceutical development. Additionally, he has worked on certain isoquinoline derivatives that exhibit anti-tumor properties, showcasing his versatility in medicinal chemistry.
Career Highlights
Throughout his career, Dumaitre has been associated with prominent companies in the pharmaceutical industry, including Laboratoires Glaxo S.A. and SmithKline Beecham Corporation. His work in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.
Collaborations
Dumaitre has collaborated with esteemed colleagues such as Nerina Dodic and Alain Claude-Marie Daugan. These partnerships have fostered a collaborative environment that has enhanced the innovation process in their respective fields.
Conclusion
Bernard Andre Dumaitre's contributions to the pharmaceutical industry, particularly in cardiovascular treatments, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile